<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04116736</url>
  </required_header>
  <id_info>
    <org_study_id>CR-6334</org_study_id>
    <nct_id>NCT04116736</nct_id>
  </id_info>
  <brief_title>ACUVUE® OASYS With Transitions™ Light Intelligent Technology™ Clinical Performance Registry</brief_title>
  <official_title>ACUVUE® OASYS With Transitions™ Light Intelligent Technology™ Clinical Performance Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry study is a one-year, one-visit, observational, prospective, open-label,
      two-arm, multi-center, multi-national, post-market study of approximately 300 patients who
      have recently been fitted with the ACUVUE® OASYS with Transitions™ and approximately 300
      patients who have recently been fitted with spherical nonphotochromic reusable marketed
      silicone hydrogel contact lenses (of any brand). Eligible subjects will be asked to complete
      a Patient Registration Questionnaire several times throughout the year.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 19, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Vision Satisfaction in Bright Lighting</measure>
    <time_frame>up to 12-month follow-up</time_frame>
    <description>Subjects will be asked to evaluate their vision satisfaction in bright lighting by rating their level of agreement with the statement &quot;I was satisfied with the quality of my vision in bright lighting with these contact lenses&quot; using a 5-point agreement Likert scale (1: Strongly Disagree, 2: Disagree, 3: Neither Agree nor Disagree, 4: Agree and 5: Strongly Agree).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall quality of vision</measure>
    <time_frame>up to 12-month follow-up</time_frame>
    <description>This will be assessed subjectively using the item &quot;I am satisfied with the overall quality of my vision with these contact lenses&quot;. The item uses a 5-point agreement scale (1: Strongly Disagree to 5: Strongly Agree).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulfrich Effect</measure>
    <time_frame>up to 12-month follow-up</time_frame>
    <description>This will be assessed subjectively using the item &quot;While wearing these lenses, my depth perception of moving objects has NOT been impacted&quot;. Subjects who disagree or strongly disagree with the statement will be considered to have experienced the Pulfrich effect.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall comfort</measure>
    <time_frame>up to 12-month follow-up</time_frame>
    <description>This will be assessed using the item &quot;How would you rate the overall comfort of these contact lenses?&quot;. The item uses the 5-point satisfaction scale, 1: Excellent, 2: Very Good, 3: Good, 4:
Fair and 5: Poor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reported serious and significant ocular adverse events</measure>
    <time_frame>up to 12-month follow-up</time_frame>
    <description>Incidence rate serious and significant ocular adverse events during the study period will be calculated (in 100 patient-year) using all available data from the entire study.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Vision Satisfaction in Bright Light</condition>
  <arm_group>
    <arm_group_label>TEST Lens</arm_group_label>
    <description>Eligible subjects that are at least 18 years old, who have been recently fitted (within the last 2 months) with the ACUVUE® OASYS with Transitions™ will be asked to complete follow-up assessments performed online at approximately 2-weeks, 4-months, and 12-months following Visit 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL Lens</arm_group_label>
    <description>Eligible subjects that are at least 18 years old, who have been recently fitted (within the last 2 months) with spherical non-photochromic reusable marketed silicone hydrogel contact lenses (of any brand) will be asked to complete follow-up assessments performed online at approximately 2-weeks, 4-months, and 12-months following Visit 1.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ACUVUE® OASYS with Transitions™</intervention_name>
    <description>JJVC Marketed Contact Lens</description>
    <arm_group_label>TEST Lens</arm_group_label>
    <other_name>TEST Lens</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Silicone Hydrogel Contact Lens</intervention_name>
    <description>Any reusable spherical silicone hydrogel brand that is approved and marketed in the country conducting the study.</description>
    <arm_group_label>CONTROL Lens</arm_group_label>
    <other_name>CONTROL Lens</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study subjects will be recruited from the clinical site's subject database and/or utilizing
        Independent Ethics Committee (IEC) or Institutional Review Board (IRB) approved materials.
        Within the sites, subjects that have received a prescription of either Intervention within
        the last 2 months will be invited to participate without regard to any demographic or other
        ocular features.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Potential subjects must satisfy all of the following criteria to be enrolled in the
        study:

          -  Contact lens neophytes or those who have recently (i.e. within last 2 months) begun
             the use of a new lens type and have purchased a supply of lenses.

          -  A minimum age of 18 years, with no maximum age.

          -  The registrant must read and sign the Informed Consent form.

          -  The registrant must appear able and willing to adhere to the instructions set forth in
             this clinical protocol.

        Exclusion Criteria:

        - Potential subjects who meet any of the following criteria will be excluded from
        participating in the study:

          -  Current participant in another research study.

          -  Employee or relative of site, or family member of Recruiting Practitioner or Johnson &amp;
             Johnson.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Graeme Young</last_name>
    <phone>+44(0) 1252 718719</phone>
    <email>research@visioncare.co.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>John Buch, OD, MS, FAAO</last_name>
    <phone>1-800-843-2020</phone>
    <email>jbuch@its.jnj.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Eyesite Opticians</name>
      <address>
        <city>Reading</city>
        <state>Berkshire</state>
        <zip>RG1 1EX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Leightons Insight Marlow</name>
      <address>
        <city>Marlow</city>
        <state>Buckinghamshire</state>
        <zip>SL7 1AE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>P Shah Opticians</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>EC1V 2NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Eyes On the Common Ltd.</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>W5 3LD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hodd Barnes Dickens Ltd</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>WC1V 6LF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Eyesite Opticians</name>
      <address>
        <city>Winchester</city>
        <state>Hampshire</state>
        <zip>SO23 9BX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>First Contact Opticians Ltd.</name>
      <address>
        <city>Eastcote</city>
        <state>Middlesex</state>
        <zip>HA5 1RJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Urquhart Opticians Ltd</name>
      <address>
        <city>Kilmarnock</city>
        <state>Scotland</state>
        <zip>KA1 2BS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Eyesite Opticians</name>
      <address>
        <city>Weybridge</city>
        <state>Surrey</state>
        <zip>KT13 8DL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chalmers Opticians Ltd</name>
      <address>
        <city>Cardiff</city>
        <state>Wales</state>
        <zip>CF243RQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 3, 2019</study_first_submitted>
  <study_first_submitted_qc>October 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 7, 2019</study_first_posted>
  <last_update_submitted>December 18, 2019</last_update_submitted>
  <last_update_submitted_qc>December 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Johnson &amp; Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu</ipd_description>
    <ipd_url>http://yoda.yale.edu</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

